BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34424540)

  • 21. Surgical treatment of adrenal carcinoma.
    Gaujoux S; Weinandt M; Bonnet S; Reslinger V; Bertherat J; Dousset B
    J Visc Surg; 2017 Oct; 154(5):335-343. PubMed ID: 28754418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
    Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
    J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
    Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.
    Lee CW; Salem AI; Schneider DF; Leverson GE; Tran TB; Poultsides GA; Postlewait LM; Maithel SK; Wang TS; Hatzaras I; Shenoy R; Phay JE; Shirley L; Fields RC; Jin LX; Pawlik TM; Prescott JD; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Weber SM
    J Gastrointest Surg; 2017 Feb; 21(2):352-362. PubMed ID: 27770290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
    Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
    Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
    Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.
    Tella SH; Kommalapati A; Yaturu S; Kebebew E
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3566-3573. PubMed ID: 29982685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of adrenocortical tumors in children.
    Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
    J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB).
    Gulack BC; Rialon KL; Englum BR; Kim J; Talbot LJ; Adibe OO; Rice HE; Tracy ET
    J Pediatr Surg; 2016 Jan; 51(1):172-7. PubMed ID: 26572849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma.
    Hue JJ; Bingmer K; Zhao H; Ammori JB; Wilhelm SM; Towe CW; Rothermel LD
    J Surg Oncol; 2021 Apr; 123(5):1238-1245. PubMed ID: 33577722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
    Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
    BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry.
    Xiao WJ; Zhu Y; Dai B; Zhang HL; Shi GH; Shen YJ; Zhu YP; Ye DW
    Oncotarget; 2015 Dec; 6(42):44955-62. PubMed ID: 26510907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
    Livhits M; Li N; Yeh MW; Harari A
    Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
    Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
    Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.